Bluebird bio earnings
Web1 day ago · The MarketWatch News Department was not involved in the creation of this content. Apr 13, 2024 (The Expresswire) -- New Research Report 2024: “ Sickle Cell Disease Treatment Market ” research ... WebMar 29, 2024 · Bluebird Bio Inc. BLUE. shares are plummeting after the company signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. In early March, the company ...
Bluebird bio earnings
Did you know?
WebFeb 23, 2024 · bluebird bio (NASDAQ:BLUE) Q4 2024 results missed analyst estimates on both EPS and revenue.; Revenue increased modestly quarter over quarter from $10M to $10M and the EPS loss narrowed to ($3.01 ... WebAug 9, 2024 · Bluebird Bio, Inc. (NASDAQ:NASDAQ:BLUE) Q2 2024 Earnings Conference Call August 9, 2024 8:00 AM ETCompany ParticipantsNick Leschly – Chief Executive OfficerElizabeth Pingpank – Direct...
WebMar 27, 2024 · bluebird bio, Inc. ( NASDAQ:BLUE - Get Rating) - Investment analysts at William Blair issued their FY2024 earnings per share (EPS) estimates for shares of bluebird bio in a report released on Wednesday, March 22nd. William Blair analyst S. Corwin forecasts that the biotechnology company will post earnings of ($4.73) per share … WebApr 10, 2024 · Bluebird Bio reports Q4 EPS (38c), consensus (44c) Reports Q4 revenue $.06M vs $1.6M last year. The Company’s cash and cash equivalents, marketable securities and restricted... 13d ago BLUE See More BLUE News > Financials Income Statment Balance Sheet Cash Flow Annual
WebApr 9, 2024 · bluebird bio (NASDAQ:BLUE) has a market capitalization of $257.05 million and generates $3.60 million in revenue each year. The biotechnology company earns $ … WebFeb 24, 2024 · For Bluebird, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has...
WebMar 3, 2024 · bluebird bio Earnings - Frequently Asked Questions When is bluebird bio's earnings date? ...
WebApr 3, 2024 · Wedbush analyst D. Nierengarten now expects that the biotechnology company will earn ($0.76) per share for the quarter, down from their prior forecast of ($0.60). The consensus estimate for bluebird bio's current full-year earnings is ($2.62) per share. i got the girl bon joviWebMar 29, 2024 · bluebird bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Operational Progress - Continued strong commercial launch for … i got the gas and the coke i don\u0027t sellWebNov 8, 2024 · bluebird bio, Inc. BLUE reported an adjusted loss of 92 cents per share (excluding restructuring charges) from continued operations for the third quarter of 2024, narrower than the Zacks Consensus ... i got the gameWebMar 29, 2024 · [email protected] Investor Contacts Courtney O’Leary Investor Relations (978) 621-7347 [email protected] Event Details bluebird bio 4th … i got the gold right here paWeb23 hours ago · Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. is the dollar worth more than the poundWebMar 4, 2024 · bluebird bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Operational Progress February 23, 2024 - … Results and Highlights Operational Progress 02/23/21 Earnings CAMBRIDGE, Mass. --(BUSINESS WIRE)- … is the dollar tree opened todayWebAug 4, 2024 · Bluebird Bio (BLUE) came out with a quarterly loss of $1.29 per share versus the Zacks Consensus Estimate of a loss of $1.31. This compares to loss of $3.58 per share a year ago. These figures are ... i got the girl lyrics